Carolina O. Matos

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Bridging the gap between 2024 EULAR/PreS Recommendations for Still's Disease and practice: the need for awareness of biomarkers and timely use of IL-1/ IL-6 inhibition.

Bridging the gap between 2024 EULAR/PreS Recommendations for Still's Disease and practice: the need for awareness of biomarkers and timely use of IL-1/ IL-6 inhibition.

Journal: ARP rheumatology
Published: July 09, 2025

Is the association between Immunoglobulin A Nephropathy and Spondyloarthritis real? A case-based review.

Is the association between Immunoglobulin A Nephropathy and Spondyloarthritis real? A case-based review.

Journal: ARP rheumatology
Published: April 02, 2025

Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis - data from a Portuguese registry.

Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis - data from a Portuguese registry.

Journal: Rheumatology (Oxford, England)
Published: January 08, 2025

CheckAP: Prevalence of psoriatic arthritis (PsA) and performance evaluation of the EARP questionnaire in the population of Portuguese patients with psoriasis followed in a dermatology setting.

CheckAP: Prevalence of psoriatic arthritis (PsA) and performance evaluation of the EARP questionnaire in the population of Portuguese patients with psoriasis followed in a dermatology setting.

Journal: ARP rheumatology
Published: January 04, 2025

Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response.

Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response.

Journal: Nature communications
Published: August 07, 2024

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.

Journal: Arthritis care & research
Published: February 21, 2024

Cycling versus swapping strategies in psoriatic arthritis: results from the rheumatic diseases Portuguese register.

Cycling versus swapping strategies in psoriatic arthritis: results from the rheumatic diseases Portuguese register.

Journal: ARP rheumatology
Published: September 20, 2023

Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.

Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.

Journal: Biomolecules
Published: January 11, 2023

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.

Journal: Cancers
Published: June 30, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026